Global Cancer Biological Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

SKU ID : QYR-21690158 | Publishing Date : 13-Sep-2022 | No. of pages : 116

Detailed TOC of Global Cancer Biological Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Biological Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Vaccines
        1.2.4 Cancer Growth Blockers
        1.2.5 Blood Cell Growth Factors
    1.3 Market by Application
        1.3.1 Global Cancer Biological Therapy Market Growth Rate by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic Laboratories
        1.3.4 Research & Academic Laboratories
        1.3.5 Pharmaceutical & Biotechnology Companies
    1.4 Study Objectives
    1.5 Years Considered
2 Market Perspective
    2.1 Global Cancer Biological Therapy Market Size (2017-2028)
    2.2 Cancer Biological Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    2.3 Global Cancer Biological Therapy Market Size by Region (2017-2022)
    2.4 Global Cancer Biological Therapy Market Size Forecast by Region (2023-2028)
    2.5 Global Top Cancer Biological Therapy Countries Ranking by Market Size
3 Cancer Biological Therapy Competitive by Company
    3.1 Global Cancer Biological Therapy Revenue by Players
        3.1.1 Global Cancer Biological Therapy Revenue by Players (2017-2022)
        3.1.2 Global Cancer Biological Therapy Market Share by Players (2017-2022)
    3.2 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Company Covered: Ranking by Cancer Biological Therapy Revenue
    3.4 Global Cancer Biological Therapy Market Concentration Ratio
        3.4.1 Global Cancer Biological Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Biological Therapy Revenue in 2021
    3.5 Global Cancer Biological Therapy Key Players Head office and Area Served
    3.6 Key Players Cancer Biological Therapy Product Solution and Service
    3.7 Date of Enter into Cancer Biological Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Global Cancer Biological Therapy Breakdown Data by Type
    4.1 Global Cancer Biological Therapy Historic Revenue by Type (2017-2022)
    4.2 Global Cancer Biological Therapy Forecasted Revenue by Type (2023-2028)
5 Global Cancer Biological Therapy Breakdown Data by Application
    5.1 Global Cancer Biological Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Biological Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Biological Therapy Revenue by Company (2020-2022)
    6.2 North America Cancer Biological Therapy Revenue by Type (2017-2028)
    6.3 North America Cancer Biological Therapy Revenue by Application (2017-2028)
    6.4 North America Cancer Biological Therapy Revenue by Country (2017-2028)
        6.4.1 U.S.
        6.4.2 Canada
7 Europe
    7.1 Europe Cancer Biological Therapy Revenue by Company (2020-2022)
    7.2 Europe Cancer Biological Therapy Revenue by Type (2017-2028)
    7.3 Europe Cancer Biological Therapy Revenue by Application (2017-2028)
    7.4 Europe Cancer Biological Therapy Revenue by Country (2017-2028)
        7.4.1 Germany
        7.4.2 France
        7.4.3 U.K.
        7.4.4 Italy
        7.4.5 Russia
8 Asia Pacific
    8.1 Asia Pacific Cancer Biological Therapy Revenue by Company (2020-2022)
    8.2 Asia Pacific Cancer Biological Therapy Revenue by Type (2017-2028)
    8.3 Asia Pacific Cancer Biological Therapy Revenue by Application (2017-2028)
    8.4 Asia Pacific Cancer Biological Therapy Revenue by Region (2017-2028)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 India
        8.4.5 Australia
        8.4.6 Taiwan
        8.4.7 Indonesia
        8.4.8 Thailand
        8.4.9 Malaysia
        8.4.10 Philippines
        8.4.11 Vietnam
9 Latin America
    9.1 Latin America Cancer Biological Therapy Revenue by Company (2020-2022)
    9.2 Latin America Cancer Biological Therapy Revenue by Type (2017-2028)
    9.3 Latin America Cancer Biological Therapy Revenue by Application (2017-2028)
    9.4 Latin America Cancer Biological Therapy Revenue by Country (2017-2028)
        9.4.1 Mexico
        9.4.2 Brazil
        9.4.3 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Cancer Biological Therapy Revenue by Company (2020-2022)
    10.2 Middle East and Africa Cancer Biological Therapy Revenue by Type (2017-2028)
    10.3 Middle East and Africa Cancer Biological Therapy Revenue by Application (2017-2028)
    10.4 Middle East and Africa Cancer Biological Therapy Revenue by Country (2017-2028)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 U.A.E
11 Company Profiles
    11.1 ELI Lilly
        11.1.1 ELI Lilly Company Details
        11.1.2 ELI Lilly Business Overview
        11.1.3 ELI Lilly Cancer Biological Therapy Products and Services
        11.1.4 ELI Lilly Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.1.5 ELI Lilly Cancer Biological Therapy SWOT Analysis
        11.1.6 ELI Lilly Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Cancer Biological Therapy Products and Services
        11.2.4 Sanofi Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.2.5 Sanofi Cancer Biological Therapy SWOT Analysis
        11.2.6 Sanofi Recent Developments
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Cancer Biological Therapy Products and Services
        11.3.4 Merck Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.3.5 Merck Cancer Biological Therapy SWOT Analysis
        11.3.6 Merck Recent Developments
    11.4 Bayer
        11.4.1 Bayer Company Details
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Cancer Biological Therapy Products and Services
        11.4.4 Bayer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.4.5 Bayer Cancer Biological Therapy SWOT Analysis
        11.4.6 Bayer Recent Developments
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Cancer Biological Therapy Products and Services
        11.5.4 Roche Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.5.5 Roche Cancer Biological Therapy SWOT Analysis
        11.5.6 Roche Recent Developments
    11.6 Novartis International
        11.6.1 Novartis International Company Details
        11.6.2 Novartis International Business Overview
        11.6.3 Novartis International Cancer Biological Therapy Products and Services
        11.6.4 Novartis International Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.6.5 Novartis International Cancer Biological Therapy SWOT Analysis
        11.6.6 Novartis International Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Cancer Biological Therapy Products and Services
        11.7.4 Pfizer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.7.5 Pfizer Cancer Biological Therapy SWOT Analysis
        11.7.6 Pfizer Recent Developments
    11.8 Bristol-Myers Squibb
        11.8.1 Bristol-Myers Squibb Company Details
        11.8.2 Bristol-Myers Squibb Business Overview
        11.8.3 Bristol-Myers Squibb Cancer Biological Therapy Products and Services
        11.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.8.5 Bristol-Myers Squibb Cancer Biological Therapy SWOT Analysis
        11.8.6 Bristol-Myers Squibb Recent Developments
    11.9 Seattle Genetics
        11.9.1 Seattle Genetics Company Details
        11.9.2 Seattle Genetics Business Overview
        11.9.3 Seattle Genetics Cancer Biological Therapy Products and Services
        11.9.4 Seattle Genetics Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.9.5 Seattle Genetics Cancer Biological Therapy SWOT Analysis
        11.9.6 Seattle Genetics Recent Developments
    11.10 Amgen
        11.10.1 Amgen Company Details
        11.10.2 Amgen Business Overview
        11.10.3 Amgen Cancer Biological Therapy Products and Services
        11.10.4 Amgen Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.10.5 Amgen Cancer Biological Therapy SWOT Analysis
        11.10.6 Amgen Recent Developments
    11.11 Takeda Pharmaceuticals
        11.11.1 Takeda Pharmaceuticals Company Details
        11.11.2 Takeda Pharmaceuticals Business Overview
        11.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Products and Services
        11.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.11.5 Takeda Pharmaceuticals Recent Developments
    11.12 GlaxoSmithKline
        11.12.1 GlaxoSmithKline Company Details
        11.12.2 GlaxoSmithKline Business Overview
        11.12.3 GlaxoSmithKline Cancer Biological Therapy Products and Services
        11.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.12.5 GlaxoSmithKline Recent Developments
    11.13 Spectrum Pharmaceuticals
        11.13.1 Spectrum Pharmaceuticals Company Details
        11.13.2 Spectrum Pharmaceuticals Business Overview
        11.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Products and Services
        11.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.13.5 Spectrum Pharmaceuticals Recent Developments
    11.14 Celgene Corporation
        11.14.1 Celgene Corporation Company Details
        11.14.2 Celgene Corporation Business Overview
        11.14.3 Celgene Corporation Cancer Biological Therapy Products and Services
        11.14.4 Celgene Corporation Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.14.5 Celgene Corporation Recent Developments
    11.15 AstraZeneca, Plc.
        11.15.1 AstraZeneca, Plc. Company Details
        11.15.2 AstraZeneca, Plc. Business Overview
        11.15.3 AstraZeneca, Plc. Cancer Biological Therapy Products and Services
        11.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.15.5 AstraZeneca, Plc. Recent Developments
    11.16 Otsuka
        11.16.1 Otsuka Company Details
        11.16.2 Otsuka Business Overview
        11.16.3 Otsuka Cancer Biological Therapy Products and Services
        11.16.4 Otsuka Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.16.5 Otsuka Recent Developments
    11.17 Eisai
        11.17.1 Eisai Company Details
        11.17.2 Eisai Business Overview
        11.17.3 Eisai Cancer Biological Therapy Products and Services
        11.17.4 Eisai Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.17.5 Eisai Recent Developments
    11.18 Abbvie
        11.18.1 Abbvie Company Details
        11.18.2 Abbvie Business Overview
        11.18.3 Abbvie Cancer Biological Therapy Products and Services
        11.18.4 Abbvie Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.18.5 Abbvie Recent Developments
    11.19 Incyte
        11.19.1 Incyte Company Details
        11.19.2 Incyte Business Overview
        11.19.3 Incyte Cancer Biological Therapy Products and Services
        11.19.4 Incyte Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022)
        11.19.5 Incyte Recent Developments
12 Cancer Biological Therapy Market Dynamics
    12.1 Cancer Biological Therapy Market Trends
    12.2 Cancer Biological Therapy Market Drivers
    12.3 Cancer Biological Therapy Market Challenges
    12.4 Cancer Biological Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details

List of Figures, Tables and Charts Available in Global Cancer Biological Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

List of Tables
    Table 1. Global Cancer Biological Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Vaccines
    Table 4. Key Players of Cancer Growth Blockers
    Table 5. Key Players of Blood Cell Growth Factors
    Table 6. Global Cancer Biological Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Cancer Biological Therapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 8. Global Cancer Biological Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global Cancer Biological Therapy Revenue Market Share by Region (2017-2022)
    Table 10. Global Cancer Biological Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 11. Global Cancer Biological Therapy Market Share by Players (2017-2022)
    Table 12. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021)
    Table 13. Ranking of Global Top Cancer Biological Therapy Companies by Revenue (US$ Million) in 2021
    Table 14. Global 5 Largest Players Market Share by Cancer Biological Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 15. Key Players Headquarters and Area Served
    Table 16. Key Players Cancer Biological Therapy Product Solution and Service
    Table 17. Date of Key Manufacturers Enter into Cancer Biological Therapy Market
    Table 18. Mergers & Acquisitions, Expansion Plans
    Table 19. Global Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 20. Global Cancer Biological Therapy Revenue Market Share by Type (2017-2022)
    Table 21. Global Cancer Biological Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 22. Global Cancer Biological Therapy Revenue Market Share by Type (2023-2028)
    Table 23. Global Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 24. Global Cancer Biological Therapy Revenue Market Share by Application (2017-2022)
    Table 25. Global Cancer Biological Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 26. Global Cancer Biological Therapy Revenue Market Share by Application (2023-2028)
    Table 27. North America Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 28. North America Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 29. North America Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 30. North America Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 31. North America Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 32. North America Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 33. North America Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 34. Europe Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 35. Europe Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 36. Europe Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 37. Europe Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 38. Europe Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 39. Europe Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 40. Europe Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 41. Asia Pacific Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 42. Asia Pacific Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 43. Asia Pacific Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Cancer Biological Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Cancer Biological Therapy Revenue by Region (2023-2028) & (US$ Million)
    Table 48. Latin America Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 49. Latin America Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 56. Middle East and Africa Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 62. ELI Lilly Company Details
    Table 63. ELI Lilly Business Overview
    Table 64. ELI Lilly Cancer Biological Therapy Product and Services
    Table 65. ELI Lilly Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 66. ELI Lilly Cancer Biological Therapy SWOT Analysis
    Table 67. ELI Lilly Recent Developments
    Table 68. Sanofi Company Details
    Table 69. Sanofi Business Overview
    Table 70. Sanofi Cancer Biological Therapy Product and Services
    Table 71. Sanofi Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 72. Sanofi Cancer Biological Therapy SWOT Analysis
    Table 73. Sanofi Recent Developments
    Table 74. Merck Company Details
    Table 75. Merck Business Overview
    Table 76. Merck Cancer Biological Therapy Product and Services
    Table 77. Merck Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 78. Merck Cancer Biological Therapy SWOT Analysis
    Table 79. Merck Recent Developments
    Table 80. Bayer Company Details
    Table 81. Bayer Business Overview
    Table 82. Bayer Cancer Biological Therapy Product and Services
    Table 83. Bayer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 84. Bayer Cancer Biological Therapy SWOT Analysis
    Table 85. Bayer Recent Developments
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Cancer Biological Therapy Product and Services
    Table 89. Roche Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 90. Roche Cancer Biological Therapy SWOT Analysis
    Table 91. Roche Recent Developments
    Table 92. Novartis International Company Details
    Table 93. Novartis International Business Overview
    Table 94. Novartis International Cancer Biological Therapy Product and Services
    Table 95. Novartis International Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 96. Novartis International Cancer Biological Therapy SWOT Analysis
    Table 97. Novartis International Recent Developments
    Table 98. Pfizer Company Details
    Table 99. Pfizer Business Overview
    Table 100. Pfizer Cancer Biological Therapy Product and Services
    Table 101. Pfizer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 102. Pfizer Cancer Biological Therapy SWOT Analysis
    Table 103. Pfizer Recent Developments
    Table 104. Bristol-Myers Squibb Company Details
    Table 105. Bristol-Myers Squibb Business Overview
    Table 106. Bristol-Myers Squibb Cancer Biological Therapy Product and Services
    Table 107. Bristol-Myers Squibb Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 108. Bristol-Myers Squibb Cancer Biological Therapy SWOT Analysis
    Table 109. Bristol-Myers Squibb Recent Developments
    Table 110. Seattle Genetics Company Details
    Table 111. Seattle Genetics Business Overview
    Table 112. Seattle Genetics Cancer Biological Therapy Product and Services
    Table 113. Seattle Genetics Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 114. Seattle Genetics Cancer Biological Therapy SWOT Analysis
    Table 115. Seattle Genetics Recent Developments
    Table 116. Amgen Company Details
    Table 117. Amgen Business Overview
    Table 118. Amgen Cancer Biological Therapy Product and Services
    Table 119. Amgen Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 120. Amgen Cancer Biological Therapy SWOT Analysis
    Table 121. Amgen Recent Developments
    Table 122. Takeda Pharmaceuticals Company Details
    Table 123. Takeda Pharmaceuticals Business Overview
    Table 124. Takeda Pharmaceuticals Cancer Biological Therapy Product and Services
    Table 125. Takeda Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 126. Takeda Pharmaceuticals Recent Developments
    Table 127. GlaxoSmithKline Company Details
    Table 128. GlaxoSmithKline Business Overview
    Table 129. GlaxoSmithKline Cancer Biological Therapy Product and Services
    Table 130. GlaxoSmithKline Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 131. GlaxoSmithKline Recent Developments
    Table 132. Spectrum Pharmaceuticals Company Details
    Table 133. Spectrum Pharmaceuticals Business Overview
    Table 134. Spectrum Pharmaceuticals Cancer Biological Therapy Product and Services
    Table 135. Spectrum Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 136. Spectrum Pharmaceuticals Recent Developments
    Table 137. Celgene Corporation Company Details
    Table 138. Celgene Corporation Business Overview
    Table 139. Celgene Corporation Cancer Biological Therapy Product and Services
    Table 140. Celgene Corporation Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 141. Celgene Corporation Recent Developments
    Table 142. AstraZeneca, Plc. Company Details
    Table 143. AstraZeneca, Plc. Business Overview
    Table 144. AstraZeneca, Plc. Cancer Biological Therapy Product and Services
    Table 145. AstraZeneca, Plc. Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 146. AstraZeneca, Plc. Recent Developments
    Table 147. Otsuka Company Details
    Table 148. Otsuka Business Overview
    Table 149. Otsuka Cancer Biological Therapy Product and Services
    Table 150. Otsuka Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 151. Otsuka Recent Developments
    Table 152. Eisai Company Details
    Table 153. Eisai Business Overview
    Table 154. Eisai Cancer Biological Therapy Product and Services
    Table 155. Eisai Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 156. Eisai Recent Developments
    Table 157. Abbvie Company Details
    Table 158. Abbvie Business Overview
    Table 159. Abbvie Cancer Biological Therapy Product and Services
    Table 160. Abbvie Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 161. Abbvie Recent Developments
    Table 162. Incyte Company Details
    Table 163. Incyte Business Overview
    Table 164. Incyte Cancer Biological Therapy Product and Services
    Table 165. Incyte Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 166. Incyte Recent Developments
    Table 167. Cancer Biological Therapy Market Trends
    Table 168. Cancer Biological Therapy Market Drivers
    Table 169. Cancer Biological Therapy Market Challenges
    Table 170. Cancer Biological Therapy Market Restraints
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Biological Therapy Sales Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Vaccines Features
    Figure 4. Cancer Growth Blockers Features
    Figure 5. Blood Cell Growth Factors Features
    Figure 6. Global Cancer Biological Therapy Sales Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Diagnostic Laboratories Case Studies
    Figure 9. Research & Academic Laboratories Case Studies
    Figure 10. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 11. Cancer Biological Therapy Report Years Considered
    Figure 12. Global Cancer Biological Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Cancer Biological Therapy Market Size 2017-2028 (US$ Million)
    Figure 14. Global Cancer Biological Therapy Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global Cancer Biological Therapy Revenue Market Share by Region in 2017 VS 2022
    Figure 16. Global Top 10 Cancer Biological Therapy Countries Ranking by Market Size (US$ Million) in 2021
    Figure 17. Global Cancer Biological Therapy Market Share by Players in 2021
    Figure 18. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Cancer Biological Therapy Revenue in 2021
    Figure 20. North America Cancer Biological Therapy Revenue Market Share by Company in 2021
    Figure 21. North America Cancer Biological Therapy Revenue Market Share by Type (2017-2028)
    Figure 22. North America Cancer Biological Therapy Revenue Market Share by Application (2017-2028)
    Figure 23. North America Cancer Biological Therapy Revenue Share by Country (2017-2028)
    Figure 24. U.S. Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 25. Canada Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 26. Europe Cancer Biological Therapy Revenue Market Share by Company in 2021
    Figure 27. Europe Cancer Biological Therapy Revenue Market Share by Type (2017-2028)
    Figure 28. Europe Cancer Biological Therapy Revenue Market Share by Application (2017-2028)
    Figure 29. Europe Cancer Biological Therapy Revenue Share by Country (2017-2028)
    Figure 30. Germany Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 31. France Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 32. U.K. Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 33. Italy Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 34. Russia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Cancer Biological Therapy Revenue Market Share by Company in 2021
    Figure 36. Asia Pacific Cancer Biological Therapy Revenue Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Cancer Biological Therapy Revenue Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Cancer Biological Therapy Revenue Share by Region (2017-2028)
    Figure 39. China Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 40. Japan Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 41. South Korea Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 42. India Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 43. Australia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 44. Taiwan Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 45. Indonesia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 46. Thailand Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 47. Malaysia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 48. Philippines Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 49. Vietnam Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 50. Latin America Cancer Biological Therapy Revenue Market Share by Company in 2021
    Figure 51. Latin America Cancer Biological Therapy Revenue Market Share by Type (2017-2028)
    Figure 52. Latin America Cancer Biological Therapy Revenue Market Share by Application (2017-2028)
    Figure 53. Latin America Cancer Biological Therapy Revenue Share by Country (2017-2028)
    Figure 54. Mexico Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 55. Brazil Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 56. Argentina Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Cancer Biological Therapy Revenue Market Share by Company in 2021
    Figure 58. Middle East and Africa Cancer Biological Therapy Revenue Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa Cancer Biological Therapy Revenue Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa Cancer Biological Therapy Revenue Share by Country (2017-2028)
    Figure 61. Turkey Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 63. U.A.E Cancer Biological Therapy Revenue (2017-2028) & (US$ Million)
    Figure 64. ELI Lilly Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 65. Sanofi Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 66. Merck Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 67. Bayer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 68. Roche Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 69. Novartis International Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 70. Pfizer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 72. Seattle Genetics Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 73. Amgen Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 74. Takeda Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 75. GlaxoSmithKline Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 76. Spectrum Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 77. Celgene Corporation Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 78. AstraZeneca, Plc. Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 79. Otsuka Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 80. Eisai Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 81. Abbvie Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 82. Incyte Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed

Keyplayers in Global Cancer Biological Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]